Nohla Therapeutics' singular passion is the development of best-in-class ex vivo expanded universal donor cellular therapies to transform the treatment of patients with cancer and other life threatening illnesses. Our products are manufactured and cryopreserved on an ongoing basis allowing for a bank of doses that are available for immediate (on demand) use. This is tremendously advantageous with regards to the ease and timing of treatment, the ability to provide repeated dosing for immune-oncology indications and reduction in patient risk and cost relative to other cell therapies.
|Employees (est.) (Jun 2020)||7||(-46%)|
Nohla Therapeutics total Funding
Nohla Therapeutics latest funding size
Time since last funding
|4 years ago|
Nohla Therapeutics investors
|ARCH Venture Partners, 5AM Ventures, The Jagen Group|
Nohla Therapeutics has 203 Twitter Followers. The number of followers has increased 0.1% month over month and decreased 0.1% quarter over quarter
When was Nohla Therapeutics founded?
Nohla Therapeutics was founded in 2015.
Who are Nohla Therapeutics key executives?
Nohla Therapeutics's key executives are Kathleen Fanning.
How many employees does Nohla Therapeutics have?
Nohla Therapeutics has 7 employees.
Who are Nohla Therapeutics competitors?
Competitors of Nohla Therapeutics include RoosterBio, Sanesco and Lophius Biosciences.
Where is Nohla Therapeutics headquarters?
Nohla Therapeutics headquarters is located at 1600 Fairview Ave E, Seattle.
Where are Nohla Therapeutics offices?
Nohla Therapeutics has offices in Seattle, Melbourne and South Melbourne.
How many offices does Nohla Therapeutics have?
Nohla Therapeutics has 3 offices.
Receive alerts for 300+ data fields across thousands of companies